Use of CTLA4-Ig in combination with conventional immunosuppressive agents to prolong allograft survival.

Source:http://linkedlifedata.com/resource/pubmed/id/9326417

Transplantation 1997 Sep 27 64 6 897-900

Download in:

View as

General Info

PMID
9326417